Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer
- PMID: 15009794
- PMCID: PMC1492143
- DOI: 10.1111/j.1525-1497.2004.30209.x
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer
Abstract
Introduction: Several recent studies have noted that African Americans disproportionately receive "watchful waiting" for the initial management of their prostate cancer. To determine whether racial/ethnic differences in the receipt of watchful waiting are explained by differences in clinical presentation and life expectancy at the time of diagnosis, we examined Surveillance, Epidemiology, and End Results (SEER)-Medicare data for men diagnosed with prostate cancer in 1994 to 1996.
Methods: Race/ethnicity, comorbidity, stage, grade, age, and expected lifespan and their association with the receipt of watchful waiting were examined in multivariate logistic regression analyses. Race-stratified logistic regression analyses were also used to examine racial/ethnic variation in the association of clinical and demographic factors with the receipt of watchful waiting among African-American, Hispanic, and non-Hispanic white men.
Results: African-American (odds ratio [OR], 1.4; 95% confidence interval [CI], 1.3 to 1.6) and Hispanic men (OR, 1.3; 95% CI, 1.1 to 1.5) were significantly more likely than non-Hispanic white men to receive watchful waiting in a multivariate model adjusted for age, comorbidity, stage, grade, and life expectancy. Advanced stage and grade, lower life expectancy, older age, and high comorbidity indices were also significantly associated with an increase in the odds of receipt of watchful waiting in multivariate analyses. In general, the association between the receipt of watchful waiting and the clinical characteristics (i.e., stage, grade, and age) were similar for the three racial/ethnic groups. In race-stratified logistic regression analyses, life expectancy was associated with an increase in the odds of receiving watchful waiting but results were statistically significant for whites only. There was also a statistically significant increase in the odds of receiving watchful waiting for African-American and white men with high comorbidity indices but not Hispanic men. The odds of receiving watchful waiting were also higher for African-American and Hispanic men who resided in census tracts where a large percentage of residents had not completed high school than for white men who resided in similar census tracts.
Conclusion: The disproportionate receipt of watchful waiting among African Americans and Hispanics is not completely explained by racial/ethnic variation in clinical characteristics or life expectancy as measured in this study. These data suggest that there are other factors that contribute to racial/ethnic differences in receipt of watchful waiting that warrant investigation.
Similar articles
-
Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.Med Care. 2004 Mar;42(3):239-50. doi: 10.1097/01.mlr.0000117361.61444.71. Med Care. 2004. PMID: 15076823
-
Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.Cancer. 2011 Oct 15;117(20):4651-8. doi: 10.1002/cncr.26103. Epub 2011 Mar 31. Cancer. 2011. PMID: 21456009 Free PMC article.
-
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.J Natl Cancer Inst. 2001 Mar 7;93(5):388-95. doi: 10.1093/jnci/93.5.388. J Natl Cancer Inst. 2001. PMID: 11238701
-
Active Surveillance for Prostate Cancer in Older Men.Clin Geriatr Med. 2025 May;41(2):187-196. doi: 10.1016/j.cger.2025.01.004. Epub 2025 Mar 10. Clin Geriatr Med. 2025. PMID: 40345773 Review.
-
Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.Prostate. 2011 Jun 15;71(9):985-97. doi: 10.1002/pros.21314. Epub 2010 Dec 28. Prostate. 2011. PMID: 21541975 Free PMC article. Review.
Cited by
-
Impact of sociodemographic factors on outcomes in patients with peritoneal malignancies following cytoreduction and chemoperfusion.J Surg Oncol. 2022 Jun;125(8):1285-1291. doi: 10.1002/jso.26843. Epub 2022 Mar 6. J Surg Oncol. 2022. PMID: 35253223 Free PMC article.
-
African American men significantly underestimate their risk of having prostate cancer at the time of biopsy.Psychooncology. 2013 Feb;22(2):338-45. doi: 10.1002/pon.2098. Epub 2011 Nov 16. Psychooncology. 2013. PMID: 22095786 Free PMC article.
-
Treatment decisions for localized prostate cancer: a concept mapping approach.Health Expect. 2015 Dec;18(6):2079-90. doi: 10.1111/hex.12175. Epub 2014 Feb 9. Health Expect. 2015. PMID: 24506829 Free PMC article.
-
Trends in prostate cancer in the United States.J Natl Cancer Inst Monogr. 2012 Dec;2012(45):152-6. doi: 10.1093/jncimonographs/lgs035. J Natl Cancer Inst Monogr. 2012. PMID: 23271766 Free PMC article.
-
Race and surgical mortality in the United States.Ann Surg. 2006 Feb;243(2):281-6. doi: 10.1097/01.sla.0000197560.92456.32. Ann Surg. 2006. PMID: 16432363 Free PMC article.
References
-
- American Cancer Society. Cancer Facts and Figures 2001. Atlanta, Ga: American Cancer Society; 2001.
-
- American Cancer Society. Cancer Facts and Figures for African Americans. Atlanta, Ga: American Cancer Society; 2001.
-
- Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review 1973–99, National Cancer Institute. Bethesda, Md:
-
- Hoffman RM, Gilliland J, Eley W, et al. Racial and ethnic differences in advanced stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001;93:388–95. - PubMed
-
- Harlan LC, Potosky A, Gilliland FD, et al. J Natl. Vol. 93. Cancer Inst; 2001. Factors associated with initial therapy for clinically localized prostate cancer: Prostate Cancer Outcomes Study; pp. 1864–71. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical